Short Interest in BiomX Inc. (NYSEAMERICAN:PHGE) Decreases By 34.4%

BiomX Inc. (NYSEAMERICAN:PHGE) saw a large decrease in short interest during the month of December. As of December 15th, there was short interest totalling 36,400 shares, a decrease of 34.4% from the November 30th total of 55,500 shares. Currently, 0.3% of the company’s shares are short sold. Based on an average trading volume of 90,000 shares, the days-to-cover ratio is currently 0.4 days.

BiomX Stock Performance

PHGE traded down $0.05 during mid-day trading on Monday, hitting $0.70. The stock had a trading volume of 247,614 shares, compared to its average volume of 109,562. The firm has a market cap of $12.72 million, a PE ratio of -0.22 and a beta of 1.31. BiomX has a 1-year low of $0.48 and a 1-year high of $8.55.

About BiomX

BiomX Inc, a clinical-stage microbiome company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), primary sclerosing cholangitis (PSC), cystic fibrosis (CF), atopic dermatitis, and colorectal cancer (CRC).